Agentic AI and Other Words We Pretend to Understand: What’s Hype vs. What Matters in Life Sciences.
ACTO united 150+ of the world’s leading life sciences innovators across 8 global cities to establish industry standards for performance, safety, measurement, and change management for Agentic AI in post-market commercialization in life sciences.
Reserve your free copy of the ACTO Responsible AI in Life Sciences (RAIL) Research Report to be among the first to receive insights and outcomes from these exclusive sessions and learn how the industry is defining the future of responsible AI.
Get on the List
About ACTO
Trusted by 14 of the top 50 pharmaceutical companies, high-growth biotechs, and leading medtech organizations, ACTO is redefining how therapies reach patients after regulatory approval. We unite human intelligence with empathetic AI through our AI-powered Field Excellence Platform and AI SuperAgents to accelerate product launches, strengthen field execution, and deepen customer engagement. By elevating training and coaching while agentifying up to 30% of the work embedded in customer-facing roles, ACTO frees teams to focus on what matters most: human connection, judgment, and strategic execution. Built to meet the industry’s highest regulatory standards, ACTO is FDA 21 CFR Part 11 validated and SOC 2 Type II certified. Learn more at www.acto.com.